|
Status |
Public on Sep 03, 2020 |
Title |
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Tumor protein p53 is a key regulator of several cellular pathways, including DNA repair, cell cycle and angiogenesis. Kevetrin exhibits p53-dependent as well as independent activity in solid tumors, while its effects on leukemic cells remain unknown. We analyzed the response of acute myeloid leukemia (AML) cell lines (TP53 wild-type: OCI-AML3 and MOLM-13; and TP53-mutant: KASUMI-1 and NOMO-1) to kevetrin at a concentration range of 85-340 μM. Kevetrin induced cell growth arrest and apoptosis in all cell lines and in primary cells, with TP53-mutant models displaying a higher sensitivity and p53 induction. Gene expression profiling revealed a common core transcriptional program altered by drug exposure and the downregulation of glycolysis, DNA repair and unfolded protein response signatures. These findings suggest that kevetrin may be a promising therapeutic option for patients with both wild-type and TP53-mutant AML.
|
|
|
Overall design |
MOLM-13 and KASUMI-1 cell lines treated with Kevetrin (or vehicle) for 6h and 48h were used for RNA extraction and hybridization on microarrays.
|
|
|
Contributor(s) |
Simonetti G, Napolitano R, De Matteis S, Martinelli G |
Citation(s) |
32945487 |
|
https://0-doi-org.brum.beds.ac.uk/10.3892/or.2020.7730
|
Submission date |
Sep 17, 2019 |
Last update date |
Oct 02, 2020 |
Contact name |
Giorgia Simonetti |
E-mail(s) |
giorgia.simonetti@irst.emr.it
|
Organization name |
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
|
Lab |
Giorgia Simonetti
|
Street address |
Via Piero Maroncelli, 40
|
City |
Meldola |
State/province |
FC |
ZIP/Postal code |
47014 |
Country |
Italy |
|
|
Platforms (1) |
GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
|
Samples (24)
|
|
Relations |
BioProject |
PRJNA565968 |